Bicalutamide was patented in 1982 and approved for medical use in 1995. It is sold under the brand name Casodex among others, is an antiandrogen medication that is primarily used to treat prostate cancer.. Reference standards of Bicalutamide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object ( [pname] => Bicalutamide-d4 Sulfide [catalogue_number] => PA STI 012750 [category_ids] => ,79,80,78,70,82,88,98, [chemical_name] => [weight] => 402.40 [form] => C18H10D4F4N2O2S [cas] => NA [pslug] => bicalutamide-d4-sulfide-pasti012750 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA STI 012750
CAS :
Molecular Formula : C18H10D4F4N2O2S
Molecular Weight : 402.40
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....